GA34 - Pelvic Pain in Women Associated with Genital Organs or Menstrual Cycle: Complete Coding Guide
1. Introduction
Pelvic pain in women associated with the genital organs or the menstrual cycle represents one of the most frequent symptoms in gynecological practice, affecting women of reproductive age and significantly impacting their quality of life. This symptom can manifest in various forms, ranging from mild discomfort during menstruation to intense and debilitating pain that interferes with daily activities, professional life, and personal relationships.
The clinical importance of this symptom transcends simple pain complaint, as it frequently signals underlying conditions that require investigation and appropriate treatment. Pelvic pain related to the genital organs or the menstrual cycle may be associated with normal physiological processes, such as ovulation and menstruation, or indicate specific pathologies that require medical intervention.
From a public health perspective, this symptom generates considerable impact, resulting in school and work absenteeism, costs with repeated medical visits, complementary examinations, and various treatments. Studies demonstrate that women with chronic pelvic pain present greater utilization of health services and significant reduction in productivity.
The correct coding of this symptom in ICD-11 is critical for multiple reasons. First, it allows for adequate recording of the prevalence and epidemiological characteristics of this condition, facilitating population studies and resource allocation. Second, it ensures appropriate documentation for administrative purposes, reimbursements, and clinical follow-up. Third, it aids in the differentiation between acute symptoms related to the menstrual cycle and chronic conditions that require a distinct approach. The precise use of code GA34 ensures effective communication between health professionals and information systems, contributing to better clinical management and continuity of care.
2. Correct ICD-11 Code
Code: GA34
Description: Pelvic pain in women associated with genital organs or the menstrual cycle
Parent category: null - Diseases of the female genital system
Official definition: A symptom affecting women, characterized by pain in the pelvic region associated with any of the genital organs or the menstrual cycle.
This code belongs to the chapter on Diseases of the female genital system in the ICD-11 structure, being classified as a specific symptom code. The designation GA34 was established to specifically capture painful manifestations related to the female reproductive system and its cyclical hormonal fluctuations.
The hierarchical structure of ICD-11 positions this code as a broad category that encompasses various more specific subcategories, allowing diagnostic refinement when applicable. It is important to understand that GA34 functions as an umbrella code for pelvic pain symptoms in women when there is clear temporal or anatomical association with the genital organs or the menstrual cycle.
The definition emphasizes two fundamental elements: the anatomical location of pain (pelvic region) and its relationship with genital structures or menstrual cyclical pattern. This specificity allows distinction of gynecological pelvic pain from other causes of lower abdominal or pelvic pain unrelated to the female reproductive system.
3. When to Use This Code
The GA34 code should be used in specific clinical scenarios where pelvic pain shows clear association with genital organs or menstrual cycle:
Scenario 1: Unspecified dysmenorrhea A 24-year-old patient reports severe pelvic pain that occurs exclusively during the first two days of each menstruation, with cramping characteristics, without an established diagnosis of endometriosis or other specific pathologies. The pain responds partially to common analgesics and interferes with her routine activities. In this case, GA34 is appropriate as it documents the painful symptom related to the menstrual cycle before further investigation or when investigations have not revealed a specific cause.
Scenario 2: Ovulatory pain (Mittelschmerz) A 28-year-old woman presents with recurrent unilateral pelvic pain that occurs consistently in the middle of the menstrual cycle, lasting from a few hours to two days, alternating between sides in different cycles. The temporal correlation with ovulation is well established through cycle monitoring. GA34 adequately captures this physiological symptom related to the menstrual cycle that, although benign, requires clinical documentation.
Scenario 3: Postcoital pelvic pain A 32-year-old patient reports deep pelvic pain that occurs during or after sexual intercourse, localized in the region of the vaginal cul-de-sac, without signs of active infection. Physical examination reveals tenderness on cervical mobilization. While investigations to identify specific causes are underway, GA34 appropriately documents the symptom related to genital organs.
Scenario 4: Cyclic pelvic pain without definitive diagnosis A 35-year-old woman presents with pelvic pain that progressively intensifies in the week before menstruation and improves with the onset of menstrual flow. Pelvic ultrasound, laboratory tests, and initial evaluation did not identify specific pathology. GA34 is appropriate for recording this symptom while diagnostic investigation continues or when no specific cause is identified.
Scenario 5: Nonspecific adnexal pain A 29-year-old patient reports pain localized in the right adnexal region, intermittent, without characteristics of acute abdomen. Imaging studies show an ovary with multiple follicles but without pathological cysts, masses, or signs of torsion. The pain shows fluctuation throughout the menstrual cycle. GA34 captures this symptom related to genital organs when there is no specific structural diagnosis.
Scenario 6: Pelvic pain under investigation A 27-year-old woman seeks care for chronic pelvic pain that worsens during menstruation. The investigative process is in its initial phase, with complementary tests scheduled. GA34 allows appropriate documentation of the main symptom while the definitive diagnosis is being established, facilitating follow-up and justifying additional investigations.
4. When NOT to Use This Code
There are specific situations where GA34 is not the appropriate code, requiring the use of more specific codes or codes from other categories:
Exclusion 1: Primary chronic visceral pain When pelvic pain presents characteristics of primary chronic pain syndrome, persisting for more than three months, associated with significant emotional distress, functional impairment, and not fully explained by identifiable pathological process in the genital organs, the appropriate code is [MG30.02](/en/code/MG30.02) (Primary chronic visceral pain) instead of GA34. The fundamental differentiation lies in the chronicity of pain and the central sensitization component of the nervous system.
Exclusion 2: Secondary chronic visceral pain If chronic pelvic pain is clearly secondary to an underlying diagnosed disease, such as advanced gynecological cancer, one should use MG30.3 (Secondary chronic visceral pain) together with the code of the causative condition. GA34 does not adequately capture the secondary and chronic nature of this manifestation.
Exclusion 3: Established specific diagnoses When there is confirmed diagnosis of endometriosis (GA10), adenomyosis (GA11), acute pelvic inflammatory disease, or other specific conditions, the code of the underlying disease should be used as priority, not GA34. The symptom code is appropriate only when the specific diagnosis is not established or as an additional code when it is desired to emphasize symptom intensity.
Exclusion 4: Pain unrelated to genital organs or menstrual cycle Pelvic pain caused by urological, gastrointestinal, musculoskeletal, or neurological conditions unrelated to genital organs or menstrual cycle should be coded according to the appropriate category of the affected system. For example, interstitial cystitis, irritable bowel syndrome, or pelvic floor dysfunction require specific codes of their respective systems.
Exclusion 5: Identified acute inflammatory processes When there is diagnosis of acute inflammatory process of the genital tract, such as salpingitis, endometritis, or tubo-ovarian abscess, codes for specific inflammatory disorders should be used instead of GA34.
5. Step-by-Step Coding Process
Step 1: Assess diagnostic criteria
The first step consists of confirming that the chief complaint is indeed pain localized to the pelvic region. The evaluation should include a detailed clinical history characterizing the pain regarding precise location, quality (cramping, stabbing, heaviness, burning), intensity, duration, triggering factors, and relieving factors.
Especially important is establishing the temporal relationship of pain with the menstrual cycle through questioning about: in which phase of the cycle the pain occurs, whether there is variation in intensity throughout the cycle, whether the pain is present during menstruation, in the ovulatory period, or in the premenstrual phase. The use of a menstrual diary can be valuable for documenting patterns.
Gynecological physical examination is fundamental, including inspection, abdominal palpation, speculum examination, and bimanual vaginal examination to identify tender points, masses, anatomical alterations, or signs of infection. The evaluation should also exclude non-gynecological causes through complete abdominal examination.
Assessment instruments such as visual analog pain scales, quality of life questionnaires, and functional assessment tools can assist in objective documentation of symptom intensity and impact.
Step 2: Verify specifiers
After confirming the symptomatic diagnosis, it is necessary to characterize relevant specifiers. The symptom duration must be established: acute (less than three months) or chronic (three months or more), as this influences coding and therapeutic approach.
Severity should be documented considering pain intensity, frequency of episodes, and functional impact. Classifications such as mild (does not significantly interfere with activities), moderate (partially interferes), or severe (incapacitating) are useful.
Specific characteristics should be recorded: cyclic versus acyclic pain, unilateral versus bilateral, superficial versus deep, presence of radiation. The relationship with specific activities such as sexual intercourse, urination, defecation, or physical activity should also be documented.
Step 3: Differentiate from other codes
Differentiation from Inflammatory disorders of the female genital tract: Inflammatory processes typically present additional signs such as fever, abnormal vaginal discharge, leukocytosis, elevation of inflammatory markers, and specific findings on physical examination and imaging. GA34 is used when there is no clear evidence of acute inflammatory process.
Differentiation from Endometriosis (GA10): Endometriosis requires diagnostic confirmation through direct visualization (laparoscopy) or highly suggestive imaging findings (endometriomas, deep implants). While pelvic pain is a cardinal symptom of endometriosis, GA34 is used when endometriosis has not been confirmed or when it is desired to code specifically the symptom in addition to the underlying diagnosis.
Differentiation from Adenomyosis (GA11): Adenomyosis presents specific imaging characteristics (myometrial thickening, myometrial cysts, linear striations) and is typically associated with menorrhagia in addition to dysmenorrhea. GA34 is appropriate when adenomyosis is not confirmed or prior to imaging investigation.
Step 4: Required documentation
Adequate documentation should include a checklist of mandatory information:
- Detailed description of pain: location, quality, intensity, duration
- Temporal relationship with menstrual cycle: cycle phase, recurrence pattern
- Associated factors: dyspareunia, dysuria, dyschezia
- Accompanying symptoms: abnormal bleeding, discharge, systemic symptoms
- Functional impact: affected activities, absenteeism, medication use
- Physical examination findings: palpation tenderness, masses, anatomical alterations
- Results of complementary tests performed
- Differential diagnoses considered and excluded
- Justification for use of GA34 if specific diagnosis not established
The record should be sufficiently detailed to allow another professional to understand the diagnostic reasoning and code selection, in addition to facilitating longitudinal follow-up of the patient.
6. Complete Practical Example
Clinical Case:
A 26-year-old female patient presents for gynecological consultation reporting recurrent pelvic pain for six months. She reports that the pain began gradually and presents a well-defined cyclical pattern. The intensity increases progressively in the five days preceding menstruation, reaching maximum peak on the first day of menstrual flow, when she rates the pain as 8/10 on a visual analog scale. The pain is described as cramping, localized to the suprapubic region and hypogastrium, with occasional radiation to the lower lumbar region.
During the most intense episodes, she needs to be absent from work, remaining on bed rest at home. She uses nonsteroidal anti-inflammatory drugs with partial relief. She denies fever, abnormal vaginal discharge, irregular bleeding, or urinary symptoms. She does not present with dyspareunia. Regular menstrual cycles every 28-30 days, with moderate flow lasting five days.
On physical examination: good general condition, normal vital signs, flat abdomen, bowel sounds present, mild tenderness on deep palpation in the hypogastrium, no palpable masses or signs of peritoneal irritation. Speculum examination: cervix with normal appearance, no lesions or pathological discharge. Vaginal examination: uterus in anteversoflexion, normal size, preserved mobility, discrete tenderness on cervical mobilization, adnexa not palpable, cul-de-sacs free.
Complementary tests requested at the consultation: transvaginal pelvic ultrasound showed uterus of normal dimensions, regular contours, no signs of adenomyosis, triphasic endometrium compatible with cycle phase, ovaries with normal appearance without masses or pathological cysts. Complete blood count, C-reactive protein, and erythrocyte sedimentation rate within normal limits.
Step-by-Step Coding:
Criteria Analysis:
-
Confirmation of pelvic pain: Present, well characterized, defined anatomical location in the pelvic region.
-
Relationship with menstrual cycle: Clearly established, with recurrent cyclical pattern, premenstrual intensification and during menstruation.
-
Relationship with genital organs: The topography, characteristics, and temporal pattern suggest origin in female reproductive organs.
-
Exclusion of specific diagnoses: Ultrasound revealed no endometriosis, adenomyosis, fibroids, or other structural pathologies. Normal inflammatory markers exclude acute inflammatory process.
-
Exclusion of primary chronic pain: Although present for six months, the pain maintains clear relationship with menstrual cycle, does not present characteristics of central sensitization or predominant neuropathic component.
-
Duration: Six months characterizes a condition with some chronicity, but still within the spectrum of symptom related to menstrual cycle without specific structural diagnosis.
Code chosen: GA34 - Pelvic pain in women associated with genital organs or menstrual cycle
Complete justification:
GA34 is the most appropriate code for this case because:
- The patient presents with main symptom of pelvic pain clearly related to the menstrual cycle, with well-established cyclical pattern
- Initial investigation revealed no specific structural diagnosis that would justify code for defined disease
- There is no evidence of acute inflammatory process that would justify code for inflammatory disorder
- Does not meet criteria for primary chronic visceral pain, as it maintains clear temporal relationship with menstrual cycle
- The code adequately captures the main symptom that prompted the consultation and justifies further investigation
- Allows appropriate documentation for follow-up and possible diagnostic reevaluation
Complementary codes:
In this specific case, there is no need for complementary codes, as no comorbidities or associated conditions requiring additional coding were identified. If the patient presented, for example, significant anxiety related to pain episodes, an additional code for anxiety disorder could be considered.
Follow-up Plan:
Coding with GA34 documents the current status and justifies clinical follow-up. If subsequent investigations reveal specific diagnosis such as endometriosis, the code should be updated. If pain persists without structural diagnosis and evolves to a pattern of chronic pain with central sensitization, reevaluation of coding will be necessary.
7. Related Codes and Differentiation
Within the Same Category:
Inflammatory disorders of the female genital tract:
When to use: This group of codes should be used when there is clear evidence of acute or chronic inflammatory process involving female genital organs, such as salpingitis, endometritis, oophoritis, or pelvic inflammatory disease. Requires presence of inflammatory signs such as fever, leukocytosis, elevation of inflammatory markers, specific findings on physical examination (severe cervical motion tenderness, adnexal masses) and/or imaging (tubal thickening, fluid collections).
Main difference vs. GA34: Inflammatory disorders represent specific diagnoses with identified or strongly suspected infectious or inflammatory etiology, whereas GA34 is a symptom code used when there is no evidence of acute inflammatory process or when the cause of pain is not clearly established. The presence of systemic signs and inflammatory markers differentiates inflammatory processes from symptomatic pelvic pain.
GA10: Endometriosis:
When to use: Endometriosis should be coded when there is diagnostic confirmation through direct visualization during surgical procedure (laparoscopy, laparotomy) with or without histopathological confirmation, or when imaging findings are highly characteristic (ovarian endometriomas, deep endometriosis nodules). It can also be used when there is strong clinical suspicion based on typical symptoms and suggestive physical examination findings, even before surgical confirmation, especially to justify empiric treatment.
Main difference vs. GA34: GA10 is a specific diagnosis of structural disease, whereas GA34 is a symptom code. A patient with confirmed endometriosis should be coded with GA10, with GA34 used only if there is a need to specifically emphasize the painful symptomatic component. Before diagnostic confirmation of endometriosis, GA34 is more appropriate to document pelvic pain under investigation.
GA11: Adenomyosis:
When to use: Adenomyosis should be coded when there is confirmation by histopathological examination (usually post-hysterectomy) or when imaging findings are characteristic: asymmetric myometrial thickening, linear striations in the myometrium, myometrial cysts, thickened junctional zone on magnetic resonance imaging. It is typically associated with progressive dysmenorrhea and menorrhagia in women in their fourth or fifth decade of life.
Main difference vs. GA34: GA11 represents a specific structural diagnosis with identifiable anatomical alterations, whereas GA34 documents a symptom without an established structural diagnosis. Adenomyosis has specific imaging characteristics that differentiate it from nonspecific pelvic pain. Patients with confirmed adenomyosis should be coded with GA11, not GA34, unless one wishes to specifically document symptomatic intensity in addition to the diagnosis.
Differential Diagnoses:
Conditions that may be confused with gynecological pelvic pain include irritable bowel syndrome (presents with relation to bowel habit, abdominal bloating, without clear relation to menstrual cycle), interstitial cystitis (predominant urinary symptoms, bladder pain), pelvic floor dysfunction (pain related to musculature, worsening with posture and physical activity), and neuropathic pain (characteristics of burning, tingling, allodynia).
Clear differentiation requires detailed clinical history identifying temporal pattern, triggering factors, associated symptoms, and specific physical examination findings. The temporal relationship with the menstrual cycle is a key element that favors GA34 over diagnoses from other systems.
8. Differences with ICD-10
In the International Classification of Diseases in its tenth revision (ICD-10), pelvic pain in women was coded in a less specific manner. The closest code would be N94.8 (Other specified conditions associated with female genital organs and the menstrual cycle) or R10.2 (Pelvic and perineal pain), depending on the context and specificity of the documentation.
ICD-10 presented important limitations in coding gynecological symptoms, frequently mixing symptoms with diagnoses and offering less granularity to capture clinical nuances. The N94 category included dysmenorrhea, but did not offer a specific code for pelvic pain related to the menstrual cycle that was not exclusively menstrual.
The main changes in ICD-11 include:
Greater specificity: GA34 was created specifically to capture pelvic pain related to genital organs or the menstrual cycle, allowing clear differentiation from other causes of abdominal or pelvic pain.
Improved hierarchical structure: ICD-11 offers subcategories that allow diagnostic refinement when appropriate, while maintaining the possibility of more general coding when a specific diagnosis is not established.
Clear separation between symptoms and diagnoses: ICD-11 establishes a clearer distinction between symptom codes (such as GA34) and specific disease codes (such as endometriosis, adenomyosis), facilitating documentation at different stages of the diagnostic process.
Practical impact: The transition to ICD-11 allows better epidemiological tracking of gynecological symptoms, facilitates clinical research by standardizing definitions, and improves communication among professionals by reducing ambiguity in coding. For health information systems, it offers more precise data on the prevalence and characteristics of female pelvic pain, assisting in resource planning and health policies.
Professionals accustomed to ICD-10 should adapt to the new structure, recognizing that GA34 offers specificity that previously required a combination of multiple codes or the use of less precise codes.
9. Frequently Asked Questions
1. How is the diagnosis of pelvic pain related to the menstrual cycle made?
The diagnosis is essentially clinical, based on detailed history and physical examination. The patient should report pain localized to the pelvic region with clear temporal relationship to the menstrual cycle or association with genital organs. The use of a menstrual diary for two to three cycles helps establish patterns. Gynecological physical examination identifies tender points, anatomical changes, or signs of specific pathology. Complementary examinations such as pelvic ultrasound are frequently requested to exclude specific structural causes, but the diagnosis of GA34 does not require abnormal imaging findings. When initial investigation is negative and pain maintains relationship with the menstrual cycle, GA34 is appropriate to document the symptom.
2. Is treatment available in public health systems?
Yes, treatment for pelvic pain related to the menstrual cycle is generally available in public health systems. Therapeutic options include analgesic medications and nonsteroidal anti-inflammatory drugs, which are widely accessible and low-cost. Hormonal contraceptives, frequently used to control cyclic pain, are also available in many public health programs. Gynecological follow-up and basic investigation with ultrasound are part of the services offered. More specialized treatments may have variable availability depending on the complexity of the local health system, but initial approaches are generally accessible.
3. How long does treatment last?
The duration of treatment varies significantly depending on the underlying cause and individual response. For pain related to the menstrual cycle without specific pathology, symptomatic treatment may be necessary cyclically during the menstrual period for an indeterminate time. Hormonal contraceptives for control of cyclic pain are frequently used for months to years, with periodic reevaluations. If further investigation identifies a specific cause such as endometriosis, the duration of treatment will be determined by the underlying diagnosis. Some cases respond well to short-term treatment, while others require prolonged management. Regular follow-up allows therapeutic adjustments based on clinical evolution.
4. Can this code be used in medical certificates?
Yes, GA34 can be used in medical certificates when pelvic pain related to the menstrual cycle or genital organs justifies absence from activities. The intensity and functional impact of pain should be documented to justify the need for absence. Incapacitating dysmenorrhea, for example, is a recognized cause of temporary absenteeism. The certificate should specify the period of necessary absence, typically corresponding to the days of greatest symptom intensity. Adequate documentation in the medical record justifies the issuance of the certificate and supports the coding used.
5. When should I seek medical care for pelvic pain?
Medical care should be sought when pelvic pain is intense, persistent, progressive, or significantly interferes with daily activities. Warning signs include sudden and severe pain, associated fever, abnormal vaginal bleeding, foul-smelling discharge, intense nausea and vomiting, or associated urinary symptoms. Pain that does not respond to common analgesics, that worsens progressively over cycles, or that is associated with difficulty becoming pregnant also justifies medical evaluation. Even mild but recurrent pain deserves investigation to identify treatable causes and prevent complications.
6. Can pelvic pain related to the menstrual cycle affect fertility?
Pelvic pain itself does not cause infertility, but it can be a symptom of conditions that affect fertility, such as endometriosis or pelvic inflammatory disease. Therefore, women with significant pelvic pain who wish to become pregnant should seek medical evaluation to investigate possible underlying causes. When pain is related to normal physiological processes (such as ovulation or primary menstruation) without structural pathology, there is no impact on fertility. Appropriate investigation allows identification and treatment of conditions that may compromise reproductive capacity.
7. Are there differences between acute and chronic pelvic pain in coding?
Yes, duration is an important criterion. Pelvic pain related to the menstrual cycle present for less than three months is considered acute or subacute, and GA34 is appropriate. When pain persists for three months or more and develops characteristics of chronic pain syndrome with central sensitization, significant emotional component, and disproportionate disability, codes for chronic pain should be considered (MG30.02 for primary chronic visceral pain). However, recurrent cyclic pain over a prolonged period but maintaining clear relationship with the menstrual cycle without characteristics of primary chronic pain can still be coded as GA34.
8. Is laparoscopy necessary to use the GA34 code?
No, laparoscopy is not necessary to use GA34. This code documents a symptom based on clinical presentation and does not require invasive procedures for its application. Diagnostic laparoscopy is indicated in specific situations when there is suspicion of conditions requiring direct visualization (such as endometriosis) or when pain is refractory to treatment and the cause remains unclear. GA34 is appropriate to document pelvic pain related to the menstrual cycle during initial investigation, when noninvasive examinations have not revealed a specific cause, or when laparoscopy is not indicated. If laparoscopy is performed and identifies a specific diagnosis, the code should be updated according to findings.
Conclusion:
The GA34 code from ICD-11 represents an essential tool for appropriate documentation of pelvic pain in women related to genital organs or the menstrual cycle. Its correct use requires clear understanding of diagnostic criteria, differentiation of related codes, and appropriate documentation. The transition from ICD-10 to ICD-11 offers greater specificity and clarity in coding this common but impactful symptom, contributing to better clinical management and more precise epidemiological data. Healthcare professionals should familiarize themselves with the indications, exclusions, and nuances of this code to ensure accurate documentation that benefits both individual care and population health.
External References
This article was prepared based on reliable scientific sources:
- 🌍 WHO ICD-11 - Pelvic pain in woman associated with female genital organs or menstrual cycle
- 🔬 PubMed Research on Pelvic pain in woman associated with female genital organs or menstrual cycle
- 🌍 WHO Health Topics
- 📊 Clinical Evidence: Pelvic pain in woman associated with female genital organs or menstrual cycle
- 📋 Ministry of Health - Brazil
- 📊 Cochrane Systematic Reviews
References verified on 2026-02-04